Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Genetic predisposition to uterine leiomyoma is determined by loci for genitourinary development and genome stability.

Välimäki N, Kuisma H, Pasanen A, Heikinheimo O, Sjöberg J, Bützow R, Sarvilinna N, Heinonen HR, Tolvanen J, Bramante S, Tanskanen T, Auvinen J, Uimari O, Alkodsi A, Lehtonen R, Kaasinen E, Palin K, Aaltonen LA.

Elife. 2018 Sep 18;7. pii: e37110. doi: 10.7554/eLife.37110.

2.

Stimulation Induced Electrographic Seizures in Deep Brain Stimulation of the Anterior Nucleus of the Thalamus Do Not Preclude a Subsequent Favorable Treatment Response.

Nora T, Heinonen H, Tenhunen M, Rainesalo S, Järvenpää S, Lehtimäki K, Peltola J.

Front Neurol. 2018 Feb 19;9:66. doi: 10.3389/fneur.2018.00066. eCollection 2018.

3.

Global metabolomic profiling of uterine leiomyomas.

Heinonen HR, Mehine M, Mäkinen N, Pasanen A, Pitkänen E, Karhu A, Sarvilinna NS, Sjöberg J, Heikinheimo O, Bützow R, Aaltonen LA, Kaasinen E.

Br J Cancer. 2017 Dec 5;117(12):1855-1864. doi: 10.1038/bjc.2017.361. Epub 2017 Oct 26.

4.

Primary inferior vena cava smooth muscle tumor with diffuse bizarre giant nuclei and low mitotic rate: a nomenclatural conundrum.

Chetty R, Kalimuthu SN, Heinonen HR.

Cardiovasc Pathol. 2017 Sep - Oct;30:1-5. doi: 10.1016/j.carpath.2017.05.007. Epub 2017 Jun 4.

PMID:
28623706
5.

Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas.

Heinonen HR, Pasanen A, Heikinheimo O, Tanskanen T, Palin K, Tolvanen J, Vahteristo P, Sjöberg J, Pitkänen E, Bützow R, Mäkinen N, Aaltonen LA.

Sci Rep. 2017 Apr 21;7(1):1015. doi: 10.1038/s41598-017-01199-0.

6.

Successful management of super-refractory status epilepticus with thalamic deep brain stimulation.

Lehtimäki K, Långsjö JW, Ollikainen J, Heinonen H, Möttönen T, Tähtinen T, Haapasalo J, Tenhunen J, Katisko J, Öhman J, Peltola J.

Ann Neurol. 2017 Jan;81(1):142-146. doi: 10.1002/ana.24821. Epub 2016 Dec 28.

PMID:
27862207
7.

MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas.

Kämpjärvi K, Mäkinen N, Mehine M, Välipakka S, Uimari O, Pitkänen E, Heinonen HR, Heikkinen T, Tolvanen J, Ahtikoski A, Frizzell N, Sarvilinna N, Sjöberg J, Bützow R, Aaltonen LA, Vahteristo P.

Br J Cancer. 2016 Jun 14;114(12):1405-11. doi: 10.1038/bjc.2016.130. Epub 2016 May 17.

8.

Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers.

Mehine M, Kaasinen E, Heinonen HR, Mäkinen N, Kämpjärvi K, Sarvilinna N, Aavikko M, Vähärautio A, Pasanen A, Bützow R, Heikinheimo O, Sjöberg J, Pitkänen E, Vahteristo P, Aaltonen LA.

Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1315-20. doi: 10.1073/pnas.1518752113. Epub 2016 Jan 19.

9.

Identification of several potential chromatin binding sites of HOXB7 and its downstream target genes in breast cancer.

Heinonen H, Lepikhova T, Sahu B, Pehkonen H, Pihlajamaa P, Louhimo R, Gao P, Wei GH, Hautaniemi S, Jänne OA, Monni O.

Int J Cancer. 2015 Nov 15;137(10):2374-83. doi: 10.1002/ijc.29616. Epub 2015 Jun 17.

10.

Clonally related uterine leiomyomas are common and display branched tumor evolution.

Mehine M, Heinonen HR, Sarvilinna N, Pitkänen E, Mäkinen N, Katainen R, Tuupanen S, Bützow R, Sjöberg J, Aaltonen LA.

Hum Mol Genet. 2015 Aug 1;24(15):4407-16. doi: 10.1093/hmg/ddv177. Epub 2015 May 10.

PMID:
25964426
11.

Perceived health-related self-efficacy associated with BMI in adults in a population-based survey.

Ovaskainen ML, Tapanainen H, Laatikainen T, Männistö S, Heinonen H, Vartiainen E.

Scand J Public Health. 2015 Mar;43(2):197-203. doi: 10.1177/1403494814566263. Epub 2015 Jan 13.

PMID:
25586112
12.

MED12 mutation frequency in unselected sporadic uterine leiomyomas.

Heinonen HR, Sarvilinna NS, Sjöberg J, Kämpjärvi K, Pitkänen E, Vahteristo P, Mäkinen N, Aaltonen LA.

Fertil Steril. 2014 Oct;102(4):1137-42. doi: 10.1016/j.fertnstert.2014.06.040. Epub 2014 Aug 6.

PMID:
25108465
13.

Genomics of uterine leiomyomas: insights from high-throughput sequencing.

Mehine M, Mäkinen N, Heinonen HR, Aaltonen LA, Vahteristo P.

Fertil Steril. 2014 Sep;102(3):621-9. doi: 10.1016/j.fertnstert.2014.06.050. Epub 2014 Aug 5. Review.

PMID:
25106763
14.

Formation of ceramophilic chitin and biohybrid materials enabled by a genetically engineered bifunctional protein.

Malho JM, Heinonen H, Kontro I, Mushi NE, Serimaa R, Hentze HP, Linder MB, Szilvay GR.

Chem Commun (Camb). 2014 Jul 14;50(55):7348-51. doi: 10.1039/c4cc02170c.

PMID:
24871427
15.

Mutation analysis of components of the Mediator kinase module in MED12 mutation-negative uterine leiomyomas.

Mäkinen N, Heinonen HR, Sjöberg J, Taipale J, Vahteristo P, Aaltonen LA.

Br J Cancer. 2014 Apr 29;110(9):2246-9. doi: 10.1038/bjc.2014.138. Epub 2014 Mar 18.

16.

Characterization of uterine leiomyomas by whole-genome sequencing.

Mehine M, Kaasinen E, Mäkinen N, Katainen R, Kämpjärvi K, Pitkänen E, Heinonen HR, Bützow R, Kilpivaara O, Kuosmanen A, Ristolainen H, Gentile M, Sjöberg J, Vahteristo P, Aaltonen LA.

N Engl J Med. 2013 Jul 4;369(1):43-53. doi: 10.1056/NEJMoa1302736. Epub 2013 Jun 5.

17.

Longitudinal changes in functional capacity: effects of socio-economic position among ageing adults.

Sulander T, Heinonen H, Pajunen T, Karisto A, Pohjolainen P, Fogelholm M.

Int J Equity Health. 2012 Dec 15;11:78. doi: 10.1186/1475-9276-11-78.

18.

Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer.

Kämpjärvi K, Mäkinen N, Kilpivaara O, Arola J, Heinonen HR, Böhm J, Abdel-Wahab O, Lehtonen HJ, Pelttari LM, Mehine M, Schrewe H, Nevanlinna H, Levine RL, Hokland P, Böhling T, Mecklin JP, Bützow R, Aaltonen LA, Vahteristo P.

Br J Cancer. 2012 Nov 6;107(10):1761-5. doi: 10.1038/bjc.2012.428. Epub 2012 Sep 20.

19.

MED12 exon 2 mutations are common in uterine leiomyomas from South African patients.

Mäkinen N, Heinonen HR, Moore S, Tomlinson IP, van der Spuy ZM, Aaltonen LA.

Oncotarget. 2011 Dec;2(12):966-9.

20.

Register-based data indicated nonparticipation bias in a health study among aging people.

Nummela O, Sulander T, Helakorpi S, Haapola I, Uutela A, Heinonen H, Valve R, Fogelholm M.

J Clin Epidemiol. 2011 Dec;64(12):1418-25. doi: 10.1016/j.jclinepi.2011.04.003. Epub 2011 Jul 20.

PMID:
21764556
21.

Type 2 diabetes prevention in the real world: three-year results of the GOAL lifestyle implementation trial.

Absetz P, Oldenburg B, Hankonen N, Valve R, Heinonen H, Nissinen A, Fogelholm M, Talja M, Uutela A.

Diabetes Care. 2009 Aug;32(8):1418-20. doi: 10.2337/dc09-0039. Epub 2009 Apr 28.

22.

Deciphering downstream gene targets of PI3K/mTOR/p70S6K pathway in breast cancer.

Heinonen H, Nieminen A, Saarela M, Kallioniemi A, Klefström J, Hautaniemi S, Monni O.

BMC Genomics. 2008 Jul 24;9:348. doi: 10.1186/1471-2164-9-348.

23.

Type 2 diabetes prevention in the "real world": one-year results of the GOAL Implementation Trial.

Absetz P, Valve R, Oldenburg B, Heinonen H, Nissinen A, Fogelholm M, Ilvesmäki V, Talja M, Uutela A.

Diabetes Care. 2007 Oct;30(10):2465-70. Epub 2007 Jun 22.

PMID:
17586741
24.

Self-rated health and indicators of SES among the ageing in three types of communities.

Nummela OP, Sulander TT, Heinonen HS, Uutela AK.

Scand J Public Health. 2007;35(1):39-47.

PMID:
17366086
25.

Rural-urban differences in health and health behaviour: a baseline description of a community health-promotion programme for the elderly.

Fogelholm M, Valve R, Absetz P, Heinonen H, Uutela A, Patja K, Karisto A, Konttinen R, Mäkelä T, Nissinen A, Jallinoja P, Nummela O, Talja M.

Scand J Public Health. 2006;34(6):632-40.

PMID:
17132597
26.

Stress among allogeneic bone marrow transplantation patients.

Heinonen H, Volin L, Zevon MA, Uutela A, Barrick C, Ruutu T.

Patient Educ Couns. 2005 Jan;56(1):62-71.

PMID:
15590224
27.

Is the evaluation of the global quality of life determined by emotional status?

Heinonen H, Aro AR, Aalto AM, Uutela A.

Qual Life Res. 2004 Oct;13(8):1347-56. Erratum in: Qual Life Res. 2005 Sep;14(7):1793-4.

PMID:
15503830
28.

Usefulness of repeated presentation of Mini-Mental State Examination as a diagnostic procedure--a population-based study.

Helkala EL, Kivipelto M, Hallikainen M, Alhainen K, Heinonen H, Tuomilehto J, Soininen H, Nissinen A.

Acta Neurol Scand. 2002 Dec;106(6):341-6.

PMID:
12460138
29.

Midlife income, occupation, APOE status, and dementia: a population-based study.

Anttila T, Helkala EL, Kivipelto M, Hallikainen M, Alhainen K, Heinonen H, Mannermaa A, Tuomilehto J, Soininen H, Nissinen A.

Neurology. 2002 Sep 24;59(6):887-93.

PMID:
12297572
30.

Axis I and II psychiatric disorders after traumatic brain injury: a 30-year follow-up study.

Koponen S, Taiminen T, Portin R, Himanen L, Isoniemi H, Heinonen H, Hinkka S, Tenovuo O.

Am J Psychiatry. 2002 Aug;159(8):1315-21.

PMID:
12153823
31.

Gender-associated differences in the quality of life after allogeneic BMT.

Heinonen H, Volin L, Uutela A, Zevon M, Barrick C, Ruutu T.

Bone Marrow Transplant. 2001 Sep;28(5):503-9.

32.

The N-methyl-D-aspartate antagonist memantine has no neuroprotective effect during hypothermic circulatory arrest: a study in the chronic porcine model.

Rimpiläinen J, Pokela M, Kiviluoma K, Vainionpää V, Hirvonen J, Ohtonen P, Jäntti V, Anttila V, Heinonen H, Juvonen T.

J Thorac Cardiovasc Surg. 2001 May;121(5):957-68; discussion 968-70.

33.

Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation.

Heinonen H, Volin L, Uutela A, Zevon M, Barrick C, Ruutu T.

Ann Hematol. 2001 Mar;80(3):137-43.

PMID:
11320897
34.

Diamond coated total hip replacements.

Lappalainen R, Anttila A, Heinonen H.

Clin Orthop Relat Res. 1998 Jul;(352):118-27.

PMID:
9678039
35.

Comparison of the central nervous system actions of taurine and N-pivaloyltaurine [proceedings].

Ahtee L, Halmekoski J, Heinonen H, Koskimies A.

Br J Pharmacol. 1979 Jul;66(3):480P. No abstract available.

36.

Extracellular proteases from soil actinomycetes. 3. Effect of growth medium and temperature on the protease production by an actinomycete, isolated from peat.

Eklund E, Heinonen H, Gyllenberg HG.

Zentralbl Bakteriol Parasitenkd Infektionskr Hyg. 1974;129(1):12-9. No abstract available.

PMID:
4408221
37.

Uraemic waste recovery. II. In vitro studies.

Setälä K, Heinonen H, Schreck-Purola I.

Proc Eur Dial Transplant Assoc. 1972;9:514-20. No abstract available.

PMID:
4668924

Supplemental Content

Loading ...
Support Center